
Investors Face August 10 Deadline in ADMA Biologics Securities Lawsuit
Investors who purchased ADMA Biologics securities between August 9, 2024, and March 25, 2026, have until August 10, 2026, to seek appointment as lead plaintiff in a pending class action lawsuit filed in the United States District Court for the District of New Jersey.




.jpg)






















